I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Surgery After Conversion Therapy With PD-1 Inhibitors Plus ..:
Wenwen Zhang
;
Bingyang Hu
;
Jun Han
...
https://www.frontiersin.org/articles/10.3389/fonc.2021.747950/full. , 2021
Link:
https://doi.org/10.3389/fonc.2021.747950
RT Journal T1
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:0cfc92fe8a154378891275102e32f488&Exemplar=1&LAN=DE A1 Wenwen Zhang A1 Bingyang Hu A1 Jun Han A1 Zhanbo Wang A1 Guangyu Ma A1 Huiyi Ye A1 Jing Yuan A1 Junning Cao A1 Ze Zhang A1 Jihang Shi A1 Mingyi Chen A1 Xun Wang A1 Yinzhe Xu A1 Yanshuang Cheng A1 Lantian Tian A1 Hongguang Wang A1 Shichun Lu PB Frontiers Media S.A. YR 2021 K1 hepatocellular carcinoma (HCC) K1 conversion therapy K1 surgery K1 systematic treatment K1 PD-1 inhibitors K1 tyrosine kinase inhibitors (TKIs) K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2021.747950/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2021.747950 DO https://doi.org/10.3389/fonc.2021.747950 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)